medigraphic.com

2017, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (3)

Autoimmune/inflammatory syndrome induced by adjuvants. A new clinical entity?

Ferrer-Cosme B, Téllez-Martínez D, Batista-Duharte A

Language: Spanish
References: 79
Page: 362-373
PDF size: 376.66 Kb.


ABSTRACT

Recently Shoenfeld and Agmon-Levin proposed a new clinical entity called autoimmune/inflammatory syndrome induced by adjuvants (ASIA), which includes four clinical entities called: 1) siliconosis, 2) Gulf War syndrome, 3) macrophage myofasciitis) and 4) post-vaccination phenomenon associated with adjuvants. They all have a common denominator: a prior exposure to immunoadjuvants, and, in addition, they also share several clinical criteria associated to chronic inflammation and autoimmune reactions. This proposal still needs to be validated by the scientific community, but nowadays is a topic of hot discussion in the literature and in various international conferences. In this revision article, we analyze the characteristics of this syndrome, the current mechanisms possibly involved in the pathogenesis, and the more recent reports regarding ASIA associated to vaccine and some foreign substances.


REFERENCES

  1. Castiblanco J, Arcos-Burgos M, Anaya JM. What is next after the genes for autoimmunity? BMC Med. 2013 Sep 4;11:197.

  2. Batista-Duharte A. [Vaccines and autoimmunity: a strange association under debate]. [Article in Spanish] Rev Peru Med Exp Salud Publica. 2012 Jun;29 (2):265-71.

  3. Shoenfeld Y, Agmon-Levin N. ‘ASIA’ - autoimmune/ inflammatory syndrome induced by adjuvants. J Autoimmun. 2011 Feb;36(1):4-8.

  4. Batista-Duharte A, Lindblad EB, Oviedo-Orta E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol Lett. 2011 Jun 10;203(2):97-105.

  5. Batista-Duharte A, Lastre M, Pérez O. [Immunological adjuvants. Determinant factors in the efficacytoxicity ratio of the contemporary vaccines]. [Article in Spanish] Enferm Infecc Microbiol Clin. 2014 Feb; 32(2):106-14.

  6. Schijns VE. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol. 2000 Aug;12(4): 456-63.

  7. O’Hagan DT, Valiante NM. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov. 2003 Sep;2(9):727-35.

  8. Tomljenovic L, Shaw CA. Aluminum vaccine adjuvants: are they safe? Curr Med Chem. 2011;18(17): 2630-7.

  9. Pellegrino P, Clementi E, Radice S. On vaccine’s adjuvants and autoimmunity: Current evidence and future perspectives. Autoimmun Rev. 2015 Oct;14 (10):880-8.

  10. Pérez O, Batista-Duharte A, González E, Zayas C, Balboa J, Cuello M, et al. Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations. Braz J Med Biol Res. 2012;45(8): 681-92.

  11. Batista-Duharte A, Portuondo D, Zeppone Carlos I, Pérez O. An approach to local immunotoxicity induced by adjuvanted vaccines. Int Immunopharmacol. 2013 Nov;17(3):526-36.

  12. Batista-Duharte A, Portuondo D, Pérez O, Carlos IZ. Systemic immunotoxicity reactions induced by adjuvanted vaccines. Int Immunopharmacol. 2014;20(1): 170-80.

  13. Miyoshi K, Miyaoka T, Kobayashi Y, Itakura T, Saijo K, Higashihara M, et al. Hypergammaglobulinemia by prolonged adjuvanticity in man. Disorders developed after augmentation mammaplasty. Nippon Iji Shimpo. 1964;2122: 9-14.

  14. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000;342(11):781-90.

  15. Kappel RM, Cohen Tervaert JW, Pruijn GJ. Autoimmune/ inflammatory syndrome induced by adjuvants (ASIA) due to silicone implant incompatibility syndrome in three sisters. Clin Exp Rheumatol. 2014 Mar-Apr;32(2):256-8.

  16. Caldeira M, Ferreira AC. Siliconosis: autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Isr Med Assoc J. 2012;14(2):137-8.

  17. Hajdu SD, Agmon-Levin N, Shoenfeld Y. Silicone and autoimmunity. Eur J Clin Invest. 2011;41(2):203-11.

  18. O’Hanlon T, Koneru B, Bayat E, Love L, Targoff I, Malley J, et al. Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum. 2004 Nov;50(11):3646-50.

  19. Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Jara LJ, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol. 2013 Apr;9(4):361-73.

  20. Asa PM, Cao Y, Garry RF. Antibodies to Squalene in Gulf War Syndrome. Exp Mol Pathol. 2000;68:55-64.

  21. Ortega-Hernandez OD, Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Ann N Y Acad Sci. 2009;1173:600-9.

  22. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol. 1997;122(2):265-8.

  23. Gherardi RK, Coquet M, Chérin P. Macrophagic myofasciitis: an emerging entity. Lancet. 1998;352:347-52.

  24. Gherardi RK, Coquet M, Chérin P, Belec L, Moretto P, Dreyfus PA, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain. 2001; 124:1821-31.

  25. Rimaniol AC, Gras G, Verdier F, Capel F, Grigoriev VB, Porcheray F, et al. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine. 2004; 22:3127-35.

  26. Gherardi RK, Authier FJ. Macrophagic myofasciitis: characterization and pat-hophysiology. Lupus. 2012; 21:184-218.

  27. Guis S, Pellissier JF, Nicoli F, Reviron D, Mattei JP, Gherardi RK. HLA-DRB1*01 and macrophagic myofasciitis. Arthritis Rheum. 2002;46:2535-7.

  28. Burkhardt H, Kalden JR. Animal models of autoimmune diseases. Rheumatol Int. 1997;17(3):91-9.

  29. Hogenesch H, Azcona-Olivera J, Scott-Moncrieff C, Snyder PW, Glickman LT. Vaccines induced autoimmunity in dogs. Adv Vet Med. 1999;41:733-47.

  30. Xu Y, Zeumer L, Reeves WH, Morel L. Induced murine models of systemic lupus erythematosus. Methods Mol Biol. 2014;1134:103-30.

  31. Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y. Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)--animal models as a proof of concept. Curr Med Chem. 2013;20(32): 4030-6.

  32. Ahmed SS, Schur PH, MacDonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun. 2014;50:1-11.

  33. Vogel G. INFLUENZA. Narcolepsy link to pandemic flu vaccine becomes clearer. Science. 2015 Jul 3; 349(6243):17.

  34. Feltelius N, Persson I, Ahlqvist-Rastad J, Andersson M, Arnheim-Dahlström L, Bergman P, et al. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden. J Intern Med. 2015;278(4):335-53.

  35. Duffy J, Weintraub E, Vellozzi C, DeStefano F. Vaccine Safety Datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology. 2014;83(20):1823-30.

  36. Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, et al.. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med. 2015;7(294):294ra105.

  37. Ahmed SS, Steinman L. Mechanistic insights into influenza vaccine-associated narcolepsy. Hum Vaccin Immunother. 2016;31:1-6.

  38. Edassery SL, Shatavi SV, Kunkel JP, Hauer C, Brucker C, Penumatsa K, et al. Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril. 2010;94 (7):2636-41.

  39. Zhen X, Qiao J, Li R, Wang L, Liu P. Serologic autoimmunologic parameters in women with primary ovarian insufficiency. BMC Immunol. 2014 Mar 10; 15:11.

  40. Ebrahimi M, Akbari Asbagh F. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015;13(8):461-72.

  41. Forges T, Monnier-Barbarino P, Faure GC, Bene MC. Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update. 2004;10(2):163-75.

  42. Shamilova NN, Marchenko LA, Dolgushina NV, Zaletaev DV, Sukhikh GT. The role of genetic and autoimmune factors in premature ovarian failure. J Assist Reprod Genet. 2013;30(5):617-22.

  43. Oktem O, Guzel Y, Aksoy S, Aydin E, Urman B. Ovarian function and reproductive outcomes of female patients with systemic lupus erythematosus and the strategies to preserve their fertility. Obstet Gynecol Surv. 2015;70(3):196-210.

  44. Little DT, Ward HR. Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination. BMJ Case Rep. 2012; doi:10.1136/bcr-2012-006879.

  45. Little DT, Ward HR. Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice. J Investig Med High Impact Case Rep. 2014;2(4): 2324709614556129.

  46. Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y. Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants. Am J Reprod Immunol. 2013;70(4):309-16.

  47. Gruber N, Shoenfeld Y. A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis. Curr Opin Obstet Gynecol. 2015;27(4):265-70.

  48. Pellegrino P, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, et al. The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Immunol Res. 2015;61(1-2):90-6.

  49. Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 2003;289(24):3283-9.

  50. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol. 2004;43(9):1503-10.

  51. Eckart RE, Love SS, Atwood JE, Arness MK, Cassimatis DC, Campbell CL, et al. Incidence and followup of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol. 2004;44(1):201-5.

  52. Morgan J, Roper MH, Sperling L, Schieber RA, Heffelfinger JD, Casey CG, et al. Myocarditis, pericarditis,and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003. Clin Infect Dis. 2008;46 Suppl 3:S242-50.

  53. Gami AS, Murphy J, Cooper LT Jr. Cautious interpretation of data regarding myopericarditis associated with smallpox vaccination. J Am Coll Cardiol. 2005;45(1):160-1.

  54. Engler RJ, Nelson MR, Collins LC Jr, Spooner C, Hemann BA, Gibbs BT, et al. A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination. PLos One. 2015;10(3):e0118283.

  55. Ibáñez S, Iruretagoyena M, Gutiérrez MA. New alternatives for the treatment of antiphospholipid syndrome. A literature review. Rev Med Chil. 2013;141 (8):1041-8.

  56. Blank M, Israeli E, Shoenfeld Y. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Lupus. 2012; 21(7):711-4.

  57. Poddighe D, Castelli L, Marseglia GL, Bruni P. A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder? Immunol Res. 2014;60(2-3):236-46.

  58. Smigoc SD, Mendez A, Kunilo JS, Bratanic N, Bratina N, Battelino T, et al. High-risk genotypes HLADR3- DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Autoimmunity. 2016;20:1-8.

  59. Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol. 2006;18(6):665-9.

  60. Pitkanen J, Peterson P. Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 2003;4(1):12-21.

  61. Li S, Wan J, Anderson W, Sun H, Zhang H, Peng X, et al. Downregulation of IL-10 secretion by Treg cells in osteoarthritis is associated with a reduction in Tim-3 expression. Biomed Pharmacother. 2016; 79:159-65.

  62. Waisbren BA. Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complementarity in the presence of an immunologic adjuvant and specific HLA patterns. Medical Hypotheses. 2008;70:346-8.

  63. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985 Nov 29;230(4729):1043-5.

  64. Zheng MM, Zhang XH. Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats. Biochem Biophys Res Commun. 2014;443(3):1118-23.

  65. Massilamany C, Asojo OA, Gangaplara A, Steffen D, Reddy J. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice. Int Immunol. 2011;23(12): 729-39.

  66. Batista-Duharte A, Téllez B, Tamayo M, Portuondo D, Cabrera O, Sierra G, et al. In silico identification of molecular mimicry between T-cell epitopes of Neisseria meningitidis B and the human proteome. Rev Peru Med Exp Salud Publica. 2013;30(3):441-5.

  67. Stanfield RL, de Castro C, Marzaioli AM, Wilson IA, Pantophlet R. Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose. Glycobiology. 2015;25(4):412-9.

  68. Guimarães LE, Baker B, Perricone C, Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol Res. 2015;100:190-209.

  69. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses. 2001;56:462-7.

  70. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med. 2003;228:660-4.

  71. Gerber JS, Offit PA. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis. 2009 Feb 15;48 (4):456-61.

  72. Gadad BS, Li W, Yazdani U, Grady S, Johnson T, Hammond J, et al. Administration of thimerosal-containing vaccines to infant rhesus macaques does not result in autism-like behavior or neuropathology. Proc Natl Acad Sci USA. 2015;112:12498-503.

  73. Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Ramirez P, Gayosso-Rivera JA, Anduaga-Domin guez H, et al. Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld’s syndrome). Lupus. 2012;21(2):128-35.

  74. Rodríguez PC, Calvo MS, Molina ZC, Durán J M, Martínez NS. Toxic oil syndrome: 30 years after. Rev Esp Med Legal. 2011;37(4):155-61.

  75. Clottens FL, Verbeken EK, Demedts M, Nemery B. Pulmonary toxicity of components of textile paint linked to the Ardystil syndrome: intratracheal administration in hamsters. Occup Environ Med. 1997;54(6):376-87.

  76. Alijotas-Reig J. Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria. Lupus. 2015;24(10):1012-8.

  77. Luján L, Pérez M, Salazar E, Álvarez N, Gimeno M, Pinczowski P, et al. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep. Immunol Res. 2013;56(2-3): 317-24.

  78. Esposito S, Prada E, Mastrolia MV, Tarantino G, Codecà C, Rigante D. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background. Immunol Res. 2014; 60(2-3):366-75.

  79. Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1-16.




2020     |     www.medigraphic.com